With a market cap of $5.2 billion, NuScale isn't cheap, at 14 times its projected sales for 2027. It's still issuing new shares and won't turn a profit anytime soon, but it still held $521 million in ...

A study has found that venom from an Amazonian scorpion may kill breast cancer cells, offering hope for a new treatment ...